Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FTO-IN-8
Cat. No.:
OB0425LY-179
Appearance:
Oil
Purity:
98.03%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
FTO-IN-8 is an inhibitor of FTO with specificity. This compound interferes with the role of FTO in RNA demethylation.
Synonyms:
2640366-38-5; 1-(5-(2-Chlorophenyl)furan-2-yl)-N-((3-(pyrrolidin-1-yl)oxetan-3-yl)methyl)methanamine
CAS No.:
2640366-38-5
Compound CID:
164886650
Formula:
C19H23ClN2O2
Formula Weight:
346.85
Specification
Target:
Fat mass and obesity-associated protein (FTO)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
FTO-IN-8 The applications of FTO-IN-8 include the study of metabolic diseases, obesity and neurodegenerative diseases, and are particularly important in the regulation of appetite and energy metabolism.
